Publications by authors named "Mitchell Nides"

Claim this Profile
V
Varenicline Over-The-Counter Trial on Efficacy and Safety.
Jennifer Pearson, Mitchell A Nides, Alana Cataldo, Marisol Martinez, Jackie Morales

Nicotine Tob Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of the impact of myblu electronic nicotine delivery system e-liquid nicotine strength on self-reported measures of dependence.
Ian M Fearon, Ryan G N Seltzer, Trisha L Houser, Andrew Tope, Xavier Cahours, Mitchell Nides

Drug Test Anal· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curiosity and intentions to use myblu e-cigarettes and an examination of the 'gateway' theory: Data from cross-sectional nationally representative surveys.
Ian M Fearon, Ryan G N Seltzer, Trisha L Houser, Andrew Tope, Xavier Cahours, Mitchell Nides

Drug Test Anal· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytisinicline for Smoking Cessation: A Randomized Clinical Trial.
Nancy A Rigotti, Neal L Benowitz, Judith Prochaska, Scott Leischow, Mitchell Nides

JAMA· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial).
Mitchell Nides, Nancy A Rigotti, Neal Benowitz, Anthony Clarke, Cindy Jacobs

Nicotine Tob Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic Setting.
Mitchell Nides, Tobias Danielsson, Frederick Saunders, Roland Perfekt, Roxanne Kapikian

Nicotine Tob Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA.
Christopher Russell, Neil McKeganey, Tiffany Dickson, Mitchell Nides

Harm Reduct J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine Lozenges in the Relief of Behaviorally Provoked Craving.
Mitchell Nides, Gilbert Marava Shanga, Amanda Bishop, William D Becker

Am J Health Behav· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokers.
Daniel Du, Mitchell Nides, James Borders, Alex Selmani, William Waverczak

Psychopharmacology (Berl)· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system.
Mitchell A Nides, Scott J Leischow, Meghna Bhatter, Michael Simmons

Am J Health Behav· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.
Mitchell Nides, Elbert D Glover, Victor I Reus, Arden G Christen, Barry J Make

Am J Health Behav· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on pharmacologic options for smoking cessation treatment.
Mitchell Nides

Am J Med· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hollywood quits--behind the scenes of a Hollywood-based smoking cessation program.
Mitchell Nides, Lisa M Hund, Sharon Carothers, Kristen L McCausland, Jennifer C Duke

Am J Health Behav· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).
Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, Anne Callens

BMC Clin Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
Mitchell Nides, Scott Leischow, Linda Sarna, Sarah E Evans

Prev Cardiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Mitchell Nides, Cheryl Oncken, David Gonzales, Stephen Rennard, Eric J Watsky

Arch Intern Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Cheryl Oncken, David Gonzales, Mitchell Nides, Stephen Rennard, Eric Watsky

Arch Intern Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
David Gonzales, Stephen I Rennard, Mitchell Nides, Cheryl Oncken, Salomon Azoulay

JAMA· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative testing of 5 nicotine systems: initial use and preferences.
Nina G Schneider, Richard E Olmstead, Mitchell Nides, Freny Vaghaiwalla Mody, Pamela Otte-Colquette

Am J Health Behav· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking reduction in the Lung Health Study.
John Hughes, Paula Lindgren, John Connett, Mitchell Nides,

Nicotine Tob Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.
Dorothy K Hatsukami, Stephen Rennard, Manoj K Patel, Michael Kotlyar, Robert Malcolm, Mitchell A Nides

Am J Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Stevens S Smith, Douglas E Jorenby, Scott J Leischow, Mitchell A Nides, Stephen I Rennard

Nicotine Tob Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years.
Robert P Murray, John E Connett, Joseph A Istvan, Mitchell A Nides, Shelly Rempel-Rossum

Nicotine Tob Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior nicotine replacement therapy on smoking cessation efficacy.
Michael J Durcan, Jonathan White, Douglas E Jorenby, Michael C Fiore, Stephen I Rennard, Mitchell A Nides

Am J Health Behav· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis